Premium
Mucopolysaccharidosis: Cardiologic features and effects of enzyme‐replacement therapy in 24 children with MPS I, II and VI
Author(s) -
Brands Marion M. M. G.,
FrohnMulder Ingrid M.,
Hagemans Marloes L. C.,
Hop Wim C. J.,
Oussoren Esmee,
Helbing Wim A.,
Ploeg Ans T.
Publication year - 2013
Publication title -
journal of inherited metabolic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 102
eISSN - 1573-2665
pISSN - 0141-8955
DOI - 10.1007/s10545-011-9444-z
Subject(s) - enzyme replacement therapy , medicine , cardiology , mitral regurgitation , left ventricular hypertrophy , muscle hypertrophy , regurgitation (circulation) , fabry disease , ejection fraction , mucopolysaccharidosis , disease , heart failure , blood pressure
We determined the cardiologic features of children with MPS I, II and VI, and evaluated the effect of enzyme‐replacement therapy (ERT) on cardiac disease. Twenty‐four children aged 1‐18 years with MPS I, II or VI were prospectively evaluated with echocardiogram and electrocardiogram from the start of enzyme‐replacement therapy up to 6 years of treatment. At start of therapy, 66% had abnormal cardiac geometric features. Left‐ventricular mass index (LVMI) was increased in half of the patients, due mainly to concentric hypertrophy in MPS I and II and to eccentric hypertrophy in MPS VI. Regurgitation was most severe in a subgroup of young MPS VI patients (<5 years) at the mitral valve. At baseline, all patients had abnormal valves. The ECG showed no clear rhythm or conduction abnormalities; neither, in most patients, did it reflect the hypertrophy. After ERT, the LVMI Z‐score normalized in 70% of the patients who had a Z‐score > 2. LVMI Z‐scores decreased significantly in patients with MPS I and MPS II (p = 0.04 and p = 0.032). Despite ERT, valve regurgitation increased in 60% of the patients. We conclude that all our MPS patients have cardiac abnormalities. The most severe cardiac disease was observed in a subgroup of young MPS VI patients. While ERT had an effect on LVMI and IVSd, it apparently had little or none on valve regurgitation.